BMAL1/p53 mediating bronchial epithelial cell autophagy contributes to PM2.5-aggravated asthma

Shuai-Jun Chen1, Yi Huang2, Fan Yu2,3

  • 1Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, 13 Hang Kong Road, Wuhan, 430030, China.

Abstract

Insights

Fine particulate matter (PM2.5) worsens asthma by inhibiting BMAL1, leading to p53 increase and autophagy in airway cells. This process drives airway remodeling and asthma severity.

Area of Science:

  • Environmental Health
  • Molecular Biology
  • Respiratory Medicine

Background:

  • Fine particulate matter (PM2.5) exposure exacerbates asthma by disrupting airway epithelial cells, leading to inflammation and remodeling.
  • The precise mechanisms driving PM2.5-induced asthma remain incompletely understood.
  • Aryl hydrocarbon receptor nuclear translocator-like protein 1 (BMAL1), a key circadian regulator, is expressed in peripheral tissues and influences metabolism.

Discussion:

  • PM2.5 exposure aggravates airway remodeling and asthma severity in mouse models.
  • Reduced BMAL1 expression is critical for airway remodeling in PM2.5-exposed asthmatic mice.
  • BMAL1 regulates p53 stability by promoting its ubiquitination and degradation.

Key Insights:

  • PM2.5-induced BMAL1 inhibition leads to p53 accumulation in bronchial epithelial cells.
  • Elevated p53 promotes autophagy, which mediates collagen-I synthesis and airway remodeling.
  • The BMAL1/p53 pathway in bronchial epithelial cells drives PM2.5-aggravated asthma.

Outlook:

  • This study reveals a novel mechanism linking circadian regulation to asthma pathogenesis.
  • Targeting the BMAL1/p53-autophagy axis offers potential therapeutic strategies for PM2.5-induced asthma.
  • Further research into BMAL1's role in asthma could uncover new treatment avenues.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
498
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K